TAKE Solutions Ltd., Chennai headquartered business technology solutions provider, has announced its foray into the big data market for the Life Sciences sector, by setting up 'Intelent' - its new US-based subsidiary, with an initial investment of $3 million.

Intelent aims to address the $300 billion healthcare and life sciences market (according to projections by McKinsey) by providing clients offerings in the areas of data integration and advanced analytics.

Noting the exponential growth in data volume and variety, and shortening of technology lifecycles, TAKE has set up Intelent to address the challenge of harnessing data from multiple streams to create a competitive advantage for its clients. This investment is expected to help organizations mine their mountain of data to fulfill business and operational needs along with compliance to reduce risk, accelerate timelines and boost returns. Born out of TAKE's strong business domain and technology expertise in strategy and implementation, Intelent will provide organizations a platform for integrating and analyzing data and deriving actionable intelligence.

Commenting on the subsidiary in US, Mr. Srinivasan HR, Vice Chairman & Managing Director, TAKE Solutions said, "As domain experts in life sciences, we have understood the specific impact of this trend in business life cycles. There has been a growing importance of mining actionable insights from Big Data for strategic decision making in the life sciences space. This investment goes into areas of analytical data aggregation, mining and visualization. Insights and intelligence derived from fast-moving data sets can help inform strategy decisions, spur innovation, inspire new products, enhance customer relationships and bolster operations."